Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs BERYL DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA BERYL DRUGS LACTOSE INDIA/
BERYL DRUGS
 
P/E (TTM) x 33.2 12.6 263.7% View Chart
P/BV x 4.3 1.8 234.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LACTOSE INDIA   BERYL DRUGS
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-23
BERYL DRUGS
Mar-23
LACTOSE INDIA/
BERYL DRUGS
5-Yr Chart
Click to enlarge
High Rs9618 535.3%   
Low Rs398 523.3%   
Sales per share (Unadj.) Rs52.353.0 98.5%  
Earnings per share (Unadj.) Rs1.01.5 63.6%  
Cash flow per share (Unadj.) Rs4.73.1 150.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs32.215.9 202.5%  
Shares outstanding (eoy) m12.595.07 248.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.2 539.4%   
Avg P/E ratio x70.68.4 836.5%  
P/CF ratio (eoy) x14.54.1 354.0%  
Price / Book Value ratio x2.10.8 262.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m85465 1,319.9%   
No. of employees `000NANA-   
Total wages/salary Rs m12215 822.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m658269 244.7%  
Other income Rs m73 262.2%   
Total revenues Rs m665272 244.9%   
Gross profit Rs m11520 576.5%  
Depreciation Rs m478 575.6%   
Interest Rs m605 1,292.5%   
Profit before tax Rs m1510 148.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m32 117.4%   
Profit after tax Rs m128 157.8%  
Gross profit margin %17.47.4 235.6%  
Effective tax rate %17.522.1 78.8%   
Net profit margin %1.82.8 64.5%  
BALANCE SHEET DATA
Current assets Rs m375104 360.2%   
Current liabilities Rs m26664 413.6%   
Net working cap to sales %16.614.8 112.0%  
Current ratio x1.41.6 87.1%  
Inventory Days Days4614 321.6%  
Debtors Days Days693937 74.0%  
Net fixed assets Rs m64371 909.4%   
Share capital Rs m12651 247.1%   
"Free" reserves Rs m28030 940.9%   
Net worth Rs m40681 502.9%   
Long term debt Rs m33027 1,215.1%   
Total assets Rs m1,018175 582.3%  
Interest coverage x1.23.1 40.0%   
Debt to equity ratio x0.80.3 241.6%  
Sales to assets ratio x0.61.5 42.0%   
Return on assets %7.17.1 100.9%  
Return on equity %3.09.5 31.4%  
Return on capital %10.213.4 75.8%  
Exports to sales %00-   
Imports to sales %31.30-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m206NA-   
Fx inflow Rs m1040-   
Fx outflow Rs m2090-   
Net fx Rs m-1050-   
CASH FLOW
From Operations Rs m8125 324.9%  
From Investments Rs m-10-13 78.2%  
From Financial Activity Rs m-84-12 718.2%  
Net Cashflow Rs m-130 -11,183.3%  

Share Holding

Indian Promoters % 53.7 26.4 203.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 46.3 73.6 62.9%  
Shareholders   16,088 6,852 234.8%  
Pledged promoter(s) holding % 26.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on LACTOSE INDIA vs BERYL DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

LACTOSE INDIA vs BERYL DRUGS Share Price Performance

Period LACTOSE INDIA BERYL DRUGS S&P BSE HEALTHCARE
1-Day -1.83% -0.98% 1.18%
1-Month -2.41% -25.48% -0.75%
1-Year 226.47% 141.20% 61.82%
3-Year CAGR 73.96% 61.60% 18.16%
5-Year CAGR 33.74% 28.53% 19.79%

* Compound Annual Growth Rate

Here are more details on the LACTOSE INDIA share price and the BERYL DRUGS share price.

Moving on to shareholding structures...

The promoters of LACTOSE INDIA hold a 53.7% stake in the company. In case of BERYL DRUGS the stake stands at 26.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LACTOSE INDIA and the shareholding pattern of BERYL DRUGS.

Finally, a word on dividends...

In the most recent financial year, LACTOSE INDIA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

BERYL DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of LACTOSE INDIA, and the dividend history of BERYL DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.